MIRA INFORM REPORT

 

 

Report Date :

17.12.2012

 

IDENTIFICATION DETAILS

 

Name :

AMSTELFARMA B.V.

 

 

Registered Office :

Zuiveringweg 40, 8243PZ Lelystad

 

 

Country :

Netherlands

 

 

Date of Incorporation :

29.12.1986

 

 

Com. Reg. No.:

39064879

 

 

Legal Form :

Limited Company

 

 

Line of Business :

Wholesaler of basic and industrial chemicals

 

 

No. of Employees :

14 employees

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Status :

Moderate

Payment Behaviour :

No Complaints 

Litigation :

Clear 

 


NOTES:

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – June 30th, 2012

                                                   

Country Name

Previous Rating

(31.03.2012)

Current Rating

(30.06.2012)

Netherlands

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

Netherlands - ECONOMIC OVERVIEW

 

The Dutch economy is the fifth-largest economy in the euro-zone and is noted for its stable industrial relations, moderate unemployment and inflation, a sizable trade surplus, and an important role as a European transportation hub. Industrial activity is predominantly in food processing, chemicals, petroleum refining, and electrical machinery. A highly mechanized agricultural sector employs only 2% of the labor force but provides large surpluses for the food-processing industry and for exports. The Netherlands, along with 11 of its EU partners, began circulating the euro currency on 1 January 2002. After 26 years of uninterrupted economic growth, the Dutch economy - highly dependent on an international financial sector and international trade - contracted by 3.5% in 2009 as a result of the global financial crisis. The Dutch financial sector suffered, due in part to the high exposure of some Dutch banks to U.S. mortgage-backed securities. In 2008, the government nationalized two banks and injected billions of dollars of capital into other financial institutions, to prevent further deterioration of a crucial sector. The government also sought to boost the domestic economy by accelerating infrastructure programs, offering corporate tax breaks for employers to retain workers, and expanding export credit facilities. The stimulus programs and bank bailouts, however, resulted in a government budget deficit of 5.3% of GDP in 2010 that contrasted sharply with a surplus of 0.7% in 2008. The government of Prime Minister Mark RUTTE began implementing fiscal consolidation measures in early 2011, mainly reductions in expenditures, which resulted in an improved budget deficit of 3.8% of GDP.

 

Source : CIA

 

 

CONTACTINFORMATION

 

Company name

Amstelfarma B.V.

 

 

Tradename

Amstelfarma

 

 

Address

Zuiveringweg 40

 

8243PZ Lelystad

 

Netherlands

 

 

Mail address

Postbus 2200

 

8203AE Lelystad

 

Netherlands

Telephone number

0320295040

Telefax number

0320219655

E-mail address

info@amstelfarma.nl

Website

www.amstelfarma.nl

 

 

VAT number / RSIN

008620751

 

 

Branch(es)

Amstelfarma B.V. (39064879.0001)

 

Nijverheidsweg 37

 

2102LK HEEMSINDE

 

 

COMPANY INFORMATION

 

Handelsregisternummer            39064879

Registered in                             Chamber of commerce Gooi-, Eem- en Flevoland

Act of foundation                      29-12-1986

Date of constitution                   01-11-1986

Continuation date                      29-12-1986

Last change in statutes              14-04-1992

Legal form                                Besloten Vennootschap (Limited Company)

 


Place of constitution

Haarlem

 

Issued capital

68.067,03

 

Paid up capital

68.067,03

 

 

NACE-code

Wholesale of basic and industrial chemicals (51551)

SBI-code

Manufacture of plastics in primary forms (2016)

 

Agents involved in the sale of fuels (4612)

 

Wholesale of basic and industrial chemicals (46751)

Formal objective

Groothandel in grondstoffen en producten in het general en in chemische grondstoffen

en producten in het bijzonder; alsmede het voeren van agentschappen en vertegenwoordigingen terzake; tevens houder van een produktievergunning.

Pharmaceutische groothandel.

 

Employees

Total: 14

 

 

Employees according to CoC

Chamber of commerce: 14

 

 

Bookyear

2012

2007

2005

Number

14

19

23

Change

-26,32%

-17,39%

21,05%

 

 

 

COMPANY STRUCTURE

 

Shareholder

Amstelfarma Holding B.V.

 

Nijverheidsweg 37

 

2102LK HEEMSINDE

 

Netherlands

 

KvK: 55824390

 

Active since: 25-09-2012

 

Percentage: 100.00%

 

 

Ultimate parent company

Bogers Management B.V.

 

Nooit Gedacht 98

 

1398EG MUIDEN

 

KvK: 34137208

 

 

Holding company

Amstelfarma Holding B.V.

 

Nijverheidsweg 37

 

2102LK HEEMSINDE

 

KvK: 55824390

 

 

Affiliated companies

Waterland Laboratories B.V.

 

Zuiveringweg 40

 

8243PZ LELYSTAD

 

KvK: 39064866

 

Bank                                         ABN Amro Bank NV

Account number: 41.06.57.913

 

Real estate                                Group-property owned

 

 

MANAGEMENT

 

Management

Bogers Management B.V.

 

Nooit Gedacht 98

 

1398EG MUIDEN

 

Netherlands

 

KvK: 34137208

 

Authorization: Fully authorized

 

Position: Manager

 

Date appointed: 25-09-2012

 


PAYMENT INFORMATION

 

Payment experiences                Payments are regular, no complaints are known

Payments                                 Based on multiple payment experiences up to € 15.000

Quarter: 1 2012: 55 Average days

Quarter: 2 2012: 58 Average days

Quarter: 3 2012: 45 Average days

Quarter: 4 2012: 38 Average days

 

Quarter

 

Invoices

Current Quarter

2012

Q3

2012

Q2

2012

Q1

Total

36

100%

11.947

13.200

15.702

15.155

Within terms

20

70,9%

8.473

6.800

3.452

4.185

Delayed

0 30

16

29,1%

3.474

6.400

12.250

10.970

 

 

FINANCIAL INFORMATION

 

Annual accounts                        Although the statutory deadline, the company's annual documents are not yet

published in the register of the Chamber of Commerce.

 

Tendency                                  Not to be judged because of the absence of sufficient financial information

 

Profitability                               Not to be judged

Solvency                                  Not to be judged

Liquidity                                    Based on payment experiences the liquidity can be described as positive

Currency                                   Euro

 

 

History

 

Liability statements

Per 14-09-2012 filed a withdrawal of declaration of liability.

Consent statements Over bookyear 2011 a consent agreement is filed

Over bookyear 2010 a consent agreement is filed

Over bookyear 2009 a consent agreement is filed

Over bookyear 2008 a consent agreement is filed

Over bookyear 2007 a consent agreement is filed

 

Management

Per 25-09-2012 manager 34137208 Bogers Management B.V. appointed.

Per 25-09-2012 manager Johan Lambert van den Brink out of office.

Per 25-09-2012 is Proxy Nicolaas Cornelis Theodorus Roozendaal out of office.

Per 25-09-2012 is Proxy Josine Hoekstra-Guardian out of office.

Per 25-09-2012 is Proxy Johannes Jacobus Maria van Haperen out of office.

Per 01-09-2011 manager Nicolaas Cornelis Theodorus Roozendaal out of office.

Per 01-09-2011 is Proxy Johan Lambert van den Brink out of office.

Per 01-09-2011 is Proxy Nicolaas Cornelis Theodorus Roozendaal appointed.

Per 01-09-2011 manager Johan Lambert van den Brink appointed.

 

Modifications

Per 1-9-2011 is the responsibility of manager Johan Lambert van den Brink changed..

 

 

Company structure

 

Bogers Management B.V. (34137208)

MUIDEN

 

DJP Europe B.V. (34308441)

ZANDVOORT

Management relation

 

Amstelfarma Holding B.V. (55824390)

HEEMSINDE

Management relation

 

Waterland Laboratories B.V. (39064866)

LELYSTAD

Subsidiary

 

Amstelfarma B.V. (39064879)

Lelystad

Subsidiary

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.54.39

UK Pound

1

Rs.87.78

Euro

1

Rs.71.29

 

INFORMATION DETAILS

 

Report Prepared by :

MNL

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

----

NB

New Business

----

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.